Europe & Central Asia
Europe & Central Asia
Afghanistan
Decades of conflict have ruined Afghanistan’s economy and infrastructure and many people rely on humanitarian aid.
In 2019
307,200
outpatient consultations59,900
births assisted6,280
surgical interventions
Europe & Central Asia
Albania
MSF first worked in Albania in 1998 and closed its projects in 2000.
Europe & Central Asia
Armenia
We are focusing on implementing new regimens for patients with multidrug-resistant tuberculosis (MDR-TB) in Armenia, which has one of the highest rates of the disease in the world.
In 2018
13
people started on treatment for DR-TB21
patients on treatment for hepatitis C
Europe & Central Asia
Azerbaijan
After ten years, MSF ended work in Azerbaijan in March 2001.
Europe & Central Asia
Belarus
We are working with the Ministry of Health in Belarus to improve adherence to treatment for patients with multidrug-resistant tuberculosis (MDR-TB).
In 2019
68
people started on treatment for DR-TB
Europe & Central Asia
Belgium
Since the closure of the ‘Jungle’ camp in Calais (France) in October 2016, Belgium has seen a slow but steady rise of migrants and refugees in need of material and mental support.
In 2019
1,010
individual mental health consultations
Europe & Central Asia
Bosnia and Herzegovina
After a decade working with populations affected by the Balkan wars, we ended our work in Bosnia and Herzegovina in 2001. In 2018, we returned to assist migrants and refugees escaping war and persecution in the Middle East, Asia and Africa.
21,700
outpatient consultations1,200
individual mental health consultations
Europe & Central Asia
Bulgaria
MSF first worked in Bulgaria in 1981 and closed its projects in 2015.
Europe & Central Asia
Croatia
MSF closed its projects in Croatia in 1998.
Europe & Central Asia
France
In Paris, northern France and at the borders with Italy and Spain, migrants and refugees encounter policies and practices aimed at preventing them from settling or claiming their rights.
In 2019
4
NO. STAFF IN 20181987
YEAR MSF FIRST WORKED IN THE COUNTRY
Europe & Central Asia
Georgia
Multidrug-resistant tuberculosis (MDR-TB) is a major public health issue in Georgia: 12 per cent of all new patients and 39 per cent of those who have previously been treated for TB have a multidrug-resistant form of the disease.
In 2018
16
patients started on treatment for MDR-TB
Europe & Central Asia